Therapeutic laser system and method

Patent metadata

Field	Value
Publication number	US-11224378-B2
Application number	US-202016815743-A
Country	US
Kind code	B2
Filing date	Mar 11, 2020
Priority date	Mar 15, 2019
Publication date	Jan 18, 2022
Grant date	Jan 18, 2022

Abstract

A treatment system can include a channel generation system configured to expose an infected region of a target tissue with a laser beam traveling along an optical axis and focused at a focal volume located in or adjacent to the target tissue. The laser beam can have a wavelength ranging from about 100 nm to about 400 nm. The laser beam can be configured to generate at least a first channel in the infected region. The treatment system can also include a detection system configured to detect a first radiation generated by one or more of (i) the target tissue, (ii) a fungi coupled to the infected region in the target tissue, and (iii) an adjacent tissue located proximal to the target tissue as a result of interaction with the laser beam. The treatment system can also include a delivery system configured to deposit an active treatment agent in the at least first channel.

First claim

What is claimed is:

1. A treatment system, comprising:
a channel generation system comprising a laser configured to expose an infected region of a target tissue with a laser beam traveling along an optical axis and focused at a focal volume located in or adjacent to the target tissue, the laser beam having a wavelength ranging from about 100 nm to about 400 nm and configured to generate at least a first channel in the infected region;
a detection system comprising a sensor configured to detect a first radiation generated by one or more of (i) the target tissue, (ii) a fungi coupled to the infected region in the target tissue, and (iii) an adjacent tissue located proximal to the target tissue as a result of interaction with the laser beam; and
a delivery system comprising a reservoir configured to retain an active treatment agent and further configured to deposit the active treatment agent in the at least first channel;
wherein the channel generation system is configured to generate an array of channels in the target tissue, and wherein a pitch of the array of channels is based on a degree of infection in the target tissue.

2. The treatment system of claim 1 , further comprising a controller configured to receive a first detection signal from the detection system indicative of the detected first radiation.

3. The treatment system of claim 2 , wherein the first radiation is at least one of a fluorescence from the fungi and a fluorophore coupled to the fungi and wherein the controller is configured to determine the identity of the fungi based on the first detection signal.

4. The treatment system of claim 3 , wherein the fluorophore includes one or more of 5-ALA, an ester of ALA, and ppIX.

5. The treatment system of claim 2 , wherein the channel generation system is configured to generate at least a second channel adjacent to the first channel, the at least second channel configured to receive the active treatment agent, wherein the received active treatment agent in the first and second channels is configured to diffuse to portions of the target tissue adjacent to the first channel and the second channel.

6. The treatment system of claim 2 , wherein the target tissue is a nail plate and the adjacent tissue is a nail bed tissue, and the first channel extends from a top proximal surface of the nail plate and a bottom distal surface of the nail plate, the bottom distal surface of the nail plate adjacent to a nail bed tissue.

7. The treatment system of claim 6 , wherein the detection system is configured to detect a second radiation generated due to interaction between the laser beam and the nail bed tissue, and transmit a second detection signal indicative of interaction between the laser beam and the nail bed tissue, wherein the channel generation system is configured to terminate interaction between the laser beam and the nail plate based on reception of the second detection signal.

8. The treatment system of claim 1 , further comprising a drilling system configured to generate one or more drilled holes in the target tissue.

9. The treatment system of claim 1 , further comprising a driving system configured to drive the active treatment agent in the first channel by one or more of application of modulated pressure waves to the target tissue, application of heat to the target tissue, and application of an ultrasound wave to the target tissue.

10. The treatment system of claim 9 , wherein the modulated pressure wave is generated by directing a second laser beam on the target tissue.

11. The treatment system of claim 1 , wherein the delivery system is configured to deposit the active treatment agent in the first channel by at least spraying the active treatment agent into the first channel.

12. The treatment system of claim 1 , wherein the delivery system includes a syringe comprising a disposable unit package comprising the active treatment agent and a sealant tip configured to be applied to the first channel after the deposition of the active treatment agent.

13. The treatment system of claim 1 , wherein the active treatment agent includes one or more of a particulate, a liposome, a gel, a polymer, an emulsion, an ointment, and a suspension.

14. The treatment system of claim 1 , wherein a cross-section of the first channel oriented perpendicular to the optical axis can be one of circle, oval or rectangle.

15. The treatment system of claim 1 , wherein the array of channels in the target tissue is based on one or more of a rectangular pattern, a triangular pattern, a circular pattern, an oval pattern, a spiral pattern, and a quasi-random pattern.

16. The treatment system of claim 15 , wherein the array of channels are generated by a plurality of laser sub-beams generated by splitting the laser beam into the plurality of sub-beams.

17. The treatment system of claim 15 , wherein a distance between the centers of adjacent channels in the array of channels is one of between 2 and 10 times, between 3 and 7 times, between 4 and 6 times, and between 4 and 5 times the diameter of a channel in the array of channel.

18. The treatment system of claim 15 , wherein a diameter of the channel at a proximal opening thereof is in the range of about 30 microns to 200 microns.

19. The treatment system of claim 1 , wherein a spot diameter associated with the focal volume is about 1 to about 25 micrometers.

20. The treatment system of claim 1 , wherein the active treatment agent includes one or more of an anti-fungal drug approved for the treatment of onychomycosis.

21. A method, comprising:
exposing, by a laser of a channel generation system, an infected region of a target tissue to a laser beam having a wavelength in the range of about 100 nm to about 400 nm and traveling along an optical axis, wherein the laser beam is focused at a focal volume located in or adjacent to the target tissue to form an array of channels in the target tissue, and wherein a pitch of the array of channels is based on a degree of infection in the target tissue;
detecting, by sensor of a detection system, a first radiation generated by one or more of the target tissue, a fungi coupled to the infected region in the target tissue, and an adjacent tissue located proximal to the target tissue as a result of interaction with the laser beam;
retaining, within a reservoir of a delivery system, an active treatment agent; and
depositing, by the delivery system, the active treatment agent in at least a first channel of the array of channels.

22. The method of claim 21 , wherein the target tissue is a nail plate and the adjacent tissue is a nail bed tissue.

23. The method of claim 22 , further comprising:
receiving, by a controller, a first detection signal from the detection system indicative of the detected first radiation, and
determining, by the controller, the identity of the fungi coupled to the infected region in the target tissue based on the first detection signal.

24. The method of claim 23 , further comprising:
detecting, by the detection system, a second radiation generated due to interaction between the laser beam and the nail bed tissue,
transmitting, by the detection system, a second detection signal indicative of interaction between the laser beam and the nail bed tissue, and
terminating, by the channel generation system, the interaction between the laser beam and the nail plate based on reception of the second detection signal.

25. The method of claim 23

Assignees

• Blossom Innovations Llc
• The General Hospital
• Massachusetts Gen Hospital

Inventors

• Anderson Richard Rox
• Bhawalkar Jayant
• Manstein Dieter
• Ting Joseph
• Zuo Vincent
• Garibyan Lilit
• Lee Kachiu
• Onwudiwe Oge
• Farinelli William A

Classifications

• A61B2018/00785

  Reflected power · CPC title

• A61B2018/00708

  switching the power on or off · CPC title

• A61B2018/00315

  for treatment of particular body parts · CPC title

• A61B5/449 Primary

  Nail evaluation, e.g. for nail disorder diagnosis · CPC title

• A61K45/06

  Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca · CPC title